Dr. Donald S. Fredrickson 
September 28, 1976 
Page 4 
away. This stems largely from our awareness of the public interest considera- 
tions. This does not mean that work cannot begin immediately. In fact, it 
must if those applications are to materialize in our lifetimes. 
In this connection we want to reiterate our position. If a valid patent is 
awarded to Stanford University and the University of California, San Francisco, 
we will apply for licenses to practise those inventions. We favor the adminis- 
tration of such patents in conjunction with the Department of Health, Education, 
and Welfare as outlined in your alternative 4. And we urge that a great deal 
of careful study, soliciting many inputs, precede any final determination of 
any guidelines for recombinant DNA research by industry in the United States. 
Yours sincerely, 
REC/lmb 
CCt 
Dr. Stanley Cohen 
Dr. Carl Djerassi 
Dr. Joshua Lederberg 
Hr. Julian Stern 
Dr. Julius Tabin 
( 97 ] 
